Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer

American Journal of Roentgenology

Volumn 189, Issue 2, 2007, Pages 323-328

  Haider, Masoom A ^a   Van Der Kwast, Theodorus H ^b,c   Tanguay, Jeff ^b   Evans, Andrew J ^b   Hashmi, Ali Tahir ^a   Lockwood, Gina ^a   Trachtenberg, John ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Diffusion weighted imaging; MRI technique; Oncologic imaging; Prostate cancer; Radiologic pathologic correlation; T2 weighted imaging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROSTATE CARCINOMA; ROC CURVE; SENSITIVITY AND SPECIFICITY;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 34547610733     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2211     Document Type: Article

References (22)

1. Carroll PR, Presti JC Jr, Small E, Roach M 3rd. Focal therapy for prostate cancer 1996: maximizing outcome. Urology 1997; 49:84-94
2. Mullerad M, Hricak H, Kuroiwa K, et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 2005; 174:2158-2163
3. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000; 164:400-404
4. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging - clinicopathologic study. Radiology 1999; 213:473-480
5. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 2004; 20:654-661
6. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002; 16:196-200
7. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis: correlation with biopsy and histopathology. J Magn Reson Imaging 2006; 24:108-113
8. Schned AR, Wheeler KJ, Hodorowski CA, et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. Am J Surg Pathol 1996; 20:1501-1506
9. Metz CE, Herman BA, Shen JH. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med 1998; 17:1033-1053
10. Hajian-Tilaki KO, Hanley JA, Joseph L, Collet JP. Extension of receiver operating characteristic analysis to data concerning multiple signal detection tasks. Acad Radiol 1997; 4:222-229
11. Leisenring W, Pepe MS, Longton G. A marginal regression modelling framework for evaluating medical diagnostic tests. Stat Med 1997; 16:1263-1281
12. 1H MR spectroscopic imaging findings - initial observations. Radiology 2004; 231:717-724
13. Lovett K, Rifkin MD, McCue PA, Choi H. MR imaging characteristics of noncancerous lesions of the prostate. J Magn Reson Imaging 1992; 2:35-39
14. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195:385-390
15. Gibbs P, Tozer DJ, Liney GP, Turnbull LW. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 2001; 46:1054-1058
16. Kim CK, Park BK, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist Tomogr 2006; 30:7-11
17. Chan I, Wells W 3rd, Mulkern RV, et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging: a multichannel statistical classifier. Med Phys 2003; 30:2390-2398
18. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 1989; 141:341-345
19. Epstein JT, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 1993; 149:1478-1481
20. Kikuchi E, Scardino PT, Wheeler TM, Slawin KM, Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2004; 172:508-511
21. Olumi AF, Richie JP, Schultz DJ, D' Amico AV. Calculated volume of prostate cancer identifies patients with clinical stage T1C disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study. Urology 2000; 56:273-277
22. Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. J Urol 1994; 152:1714-1720